ALRN

Aileron Therapeutics, Inc. ALRN

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode ALRN RLFTD MGTA ALVR KRON PSTI ODTC RENB GRNA STSA
6M 7.65 % 0.00 % -10.43 % -44.83 % -11.13 % -5.66 % -83.87 % -60.56 % -57.26 % 19.57 %
YTD -6.22 % 0.00 % 70.63 % -5.22 % -9.29 % 0.00 % -83.87 % -81.39 % -73.96 % 27.63 %
1Y -56.04 % 0.00 % -35.82 % -43.65 % -29.60 % -39.76 % -83.33 % -84.80 % -92.26 % -77.51 %
3Y -76.24 % 0.00 % -90.60 % -91.91 % -83.27 % -73.54 % -78.00 % -93.93 % -96.94 % -96.07 %
5Y -85.31 % 0.00 % -92.28 % -98.32 % -96.75 % -92.54 % -99.13 % -95.79 % -96.94 % -93.49 %
10Y -99.02 % 0.00 % -95.18 % -98.32 % -96.75 % -96.89 % -98.80 % -97.59 % -96.94 % -93.49 %
From the beginning -99.02 % 0.00 % -95.18 % -98.32 % -96.75 % -99.81 % -98.80 % -97.59 % -96.94 % -93.49 %

Dividend

Satsuma Pharmaceuticals, Inc.